Drugs / Pazufloxacin Mesilate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03675841 | Jul 2018 → Jan 2019 | chronic purulent otitis media | Lee's Pharmaceutical Limited | Unknown | No outcome recorded |
| Phase 1 | NCT02592096 | Jul 2015 → Jan 2016 | otitis media | Lee's Pharmaceutical Limited | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pazufloxacin Mesilate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03675841 ↗ |
| Route | Other | “10 drips for ear dropping, 10 minutes for ear bath” NCT02592096 ↗ |